1. [1] Câmara RD, Köhler CA, Frey BN, Hyphantis TN, Carvalho AF. Validation of the Brazilian portuguese version of the premenstrual symptoms screening Tool (PSST) and association of PSST scores with health-related quality of life. Braz J Psychiatry 2017; 39: 140-146. [DOI:10.1590/1516-4446-2016-1953] [PMID]

2. [2] Marc A, Speroff L. Clinical gynecologic endocrinilogy and infertility. 8th ed. USA: Williams & Wilkins; c2011, part 1, 567-578.

3. [3] Zarei Z, Bazzazian S. The relationship between premenstrual syndrome disorder, stress and quality of life in female students. Iran J Psychiat Nurs 2015; 2: 49-58. (Persian).

4. [4] Masoumi SZ, Ataollahi M, Oshvandi K. Effect of combined use of calcium and vitamin B6 on premenstrual syndrome symptoms: a randomized clinical trial. J Caring Sci 2016; 5: 67-73. [DOI:10.15171/jcs.2016.007] [PMID] [PMCID]

5. [5] Takeda T, Tasaka K, Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 2006; 9: 209-212. [DOI:10.1007/s00737-006-0137-9] [PMID]

6. [6] Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenopausal syndrome. J Occup Environ 2005; 47: 26-33. [DOI:10.1097/01.jom.0000150209.44312.d1] [PMID]

7. [7] Shakeri Z. The relationship of lifestyle and attachmentstyle with premenstrual syndrome in Mashhad medical university student 2013. [dissertation]. Mashhad Univ Med Sci 1392; 10. (Persian).

8. [8] Milewicz A, Jedrzejuk D. Premenstrual syndrome: from etiology to treatment. Maturitas 2006; 55: S47-54. [DOI:10.1016/j.maturitas.2006.06.016]

9. [9] Siahbazi S, Behboudi-Gandevani S, Moghaddam-Banaem L, Montazeri A. Effect of zinc sulfate supplementation on premenstrual syndrome and health‐related quality of life: Clinical randomized controlled trial. J Obstet Gynaecol Res 2017; 43: 887-894. [DOI:10.1111/jog.13299] [PMID]

10. [10] Rosenfeld R, Livne D, Nevo O, Dayan L, Milloul V, Lavi S, Jacob G. Hormonal and volume dysregulation in women with premenstrual syndrome. Hypertension 2008; 51: 1225-1230. [DOI:10.1161/HYPERTENSIONAHA.107.107136] [PMID]

11. [11] Verma RK CD, Pandey AK. Review on treatment of premenstrual syndrome: from conventional to alternative approach. J Basic Clin Physiol Pharmaco 2014; 25: 319-327. [DOI:10.1515/jbcpp-2013-0072]

12. [12] Levin AM. Pre-menstrual syndrome: a new concept in its pathogenesis and treatment. Med Hypotheses 2004; 36: 130-132. [DOI:10.1016/S0306-9877(03)00239-1]

13. [13] Steege JF, Blumenthal JA. Effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res 1993; 37: 127-123. [DOI:10.1016/0022-3999(93)90079-U]

14. [14] Fallah H, Mohtashami R. A review of the pharmacological effects of Nigella sativa. J Med Plants 1390; 10: 1-14. (Persian).

15. [15] Bin Sayeed MS, Shams T, Fahim Hossain S, Rahman MR, Mostofa A, Fahim Kadir M, et al. Seeds modulate mood, anxiety and cognition in healthy adolescent males. J Ethnopharmacol 2014; 152: 156-162. [DOI:10.1016/j.jep.2013.12.050] [PMID]

16. [16] Parhizkarsup S, Latiffsup LA, Rahmansup SA, Dollahsup MA, Parichehr H. Assessing estrogenic activity of Nigella sativa in ovariectomized rats using vaginal cornification assay. African J Pharmacy Pharmacol 2011; 5: 137-142. [DOI:10.5897/AJPP10.276]

17. [17] Valizadeh NA, Zakeri HR, Shafiee A, Sarkheil P, Heshmat RA, Larijani B. The effect of nigella sativa extract on biochemical bone markers in osteopenic postmenopausal women. Iran J Endocrinol Metab 2009; 10: 571-580.

18. [18] Mehnazadeh Falahieh F. Comparison of the effects of Nigella sativa and Mefenamic acid on primary dysmenorrhea. [dissertation]. Mashhad Univ Med Sci 1394. (Persian).

19. [19] Mohammad Azam. Great elixir, Volume 3: 658-697.

20. [20] Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. J Psychosom Res 2002; 52: 223-237. [DOI:10.1016/S0022-3999(02)00297-0]

21. [21] C JE. modern management of Premenstrual syndrome. Women mental health. 2005;7(4).

22. [22] Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008; 46: 409-420. [DOI:10.1016/j.fct.2007.09.085] [PMID]

23. [23] Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 2003; 188: S56-65. [DOI:10.1067/mob.2003.403] [PMID]

24. [24] Aqel M, Shaheen R. Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J Ethnopharmacol 1996; 52: 23-26. [DOI:10.1016/0378-8741(95)01330-X]

25. [25] Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 2001; 76: 45-48. [DOI:10.1016/S0378-8741(01)00216-1]

26. [26] Tamadonfard Z, Sepehrara L, Johari H. The effect of nigella sativa extract on learning and spatial memory of adult male rats. J Jahrom Univ Med Sci 2014; 12: 27-36. (Persian). [DOI:10.29252/jmj.12.1.27]

27. [27] Rahman M, Yang DK, Kim GB, Lee SJ, Kim SJ. Nigella sativa seed extract attenuates the fatigue induced by exhaustive swimming in rats. Biomed Rep 2017; 6: 468-474. [DOI:10.3892/br.2017.866] [PMID] [PMCID]

28. [28] Fathizadeh S, Amani R, Haghighizadeh MH, Hormozi R. Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: A case-control study. Int J Reprod Biomed (Yazd) 2016; 14: 699-704. (Persian). [DOI:10.29252/ijrm.14.11.699]

29. [29] Tofighiyan T, Kooshki A, Rakhshani MH. The effects of omega-3 fatty acids on premenstrual syndrome. Iran J Obstet Gynecol Infert 2013; 15: 23-28.

30. [30] Collins A, Cerin A, Coleman G, Landgren BM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993; 81: 93-98.

31. [31] Shah Hosseini Z, Danesh MM, Amin GH, SalehiSormaghi MH, Abedian K. Double blind study of anti-primary dysmenorrhea effects of Vitagnus. J Mazendaran Univ Med Sci 2005; 16: 15-21. (Persian).

32. [1] Câmara RD, Köhler CA, Frey BN, Hyphantis TN, Carvalho AF. Validation of the Brazilian portuguese version of the premenstrual symptoms screening Tool (PSST) and association of PSST scores with health-related quality of life. Braz J Psychiatry 2017; 39: 140-146. [DOI:10.1590/1516-4446-2016-1953] [PMID]

33. [2] Marc A, Speroff L. Clinical gynecologic endocrinilogy and infertility. 8th ed. USA: Williams & Wilkins; c2011, part 1, 567-578.

34. [3] Zarei Z, Bazzazian S. The relationship between premenstrual syndrome disorder, stress and quality of life in female students. Iran J Psychiat Nurs 2015; 2: 49-58. (Persian).

35. [4] Masoumi SZ, Ataollahi M, Oshvandi K. Effect of combined use of calcium and vitamin B6 on premenstrual syndrome symptoms: a randomized clinical trial. J Caring Sci 2016; 5: 67-73. [DOI:10.15171/jcs.2016.007] [PMID] [PMCID]

36. [5] Takeda T, Tasaka K, Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 2006; 9: 209-212. [DOI:10.1007/s00737-006-0137-9] [PMID]

37. [6] Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenopausal syndrome. J Occup Environ 2005; 47: 26-33. [DOI:10.1097/01.jom.0000150209.44312.d1] [PMID]

38. [7] Shakeri Z. The relationship of lifestyle and attachmentstyle with premenstrual syndrome in Mashhad medical university student 2013. [dissertation]. Mashhad Univ Med Sci 1392; 10. (Persian).

39. [8] Milewicz A, Jedrzejuk D. Premenstrual syndrome: from etiology to treatment. Maturitas 2006; 55: S47-54. [DOI:10.1016/j.maturitas.2006.06.016]

40. [9] Siahbazi S, Behboudi-Gandevani S, Moghaddam-Banaem L, Montazeri A. Effect of zinc sulfate supplementation on premenstrual syndrome and health‐related quality of life: Clinical randomized controlled trial. J Obstet Gynaecol Res 2017; 43: 887-894. [DOI:10.1111/jog.13299] [PMID]

41. [10] Rosenfeld R, Livne D, Nevo O, Dayan L, Milloul V, Lavi S, Jacob G. Hormonal and volume dysregulation in women with premenstrual syndrome. Hypertension 2008; 51: 1225-1230. [DOI:10.1161/HYPERTENSIONAHA.107.107136] [PMID]

42. [11] Verma RK CD, Pandey AK. Review on treatment of premenstrual syndrome: from conventional to alternative approach. J Basic Clin Physiol Pharmaco 2014; 25: 319-327. [DOI:10.1515/jbcpp-2013-0072]

43. [12] Levin AM. Pre-menstrual syndrome: a new concept in its pathogenesis and treatment. Med Hypotheses 2004; 36: 130-132. [DOI:10.1016/S0306-9877(03)00239-1]

44. [13] Steege JF, Blumenthal JA. Effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res 1993; 37: 127-123. [DOI:10.1016/0022-3999(93)90079-U]

45. [14] Fallah H, Mohtashami R. A review of the pharmacological effects of Nigella sativa. J Med Plants 1390; 10: 1-14. (Persian).

46. [15] Bin Sayeed MS, Shams T, Fahim Hossain S, Rahman MR, Mostofa A, Fahim Kadir M, et al. Seeds modulate mood, anxiety and cognition in healthy adolescent males. J Ethnopharmacol 2014; 152: 156-162. [DOI:10.1016/j.jep.2013.12.050] [PMID]

47. [16] Parhizkarsup S, Latiffsup LA, Rahmansup SA, Dollahsup MA, Parichehr H. Assessing estrogenic activity of Nigella sativa in ovariectomized rats using vaginal cornification assay. African J Pharmacy Pharmacol 2011; 5: 137-142. [DOI:10.5897/AJPP10.276]

48. [17] Valizadeh NA, Zakeri HR, Shafiee A, Sarkheil P, Heshmat RA, Larijani B. The effect of nigella sativa extract on biochemical bone markers in osteopenic postmenopausal women. Iran J Endocrinol Metab 2009; 10: 571-580.

49. [18] Mehnazadeh Falahieh F. Comparison of the effects of Nigella sativa and Mefenamic acid on primary dysmenorrhea. [dissertation]. Mashhad Univ Med Sci 1394. (Persian).

50. [19] Mohammad Azam. Great elixir, Volume 3: 658-697.

51. [20] Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. J Psychosom Res 2002; 52: 223-237. [DOI:10.1016/S0022-3999(02)00297-0]

52. [21] C JE. modern management of Premenstrual syndrome. Women mental health. 2005;7(4).

53. [22] Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008; 46: 409-420. [DOI:10.1016/j.fct.2007.09.085] [PMID]

54. [23] Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 2003; 188: S56-65. [DOI:10.1067/mob.2003.403] [PMID]

55. [24] Aqel M, Shaheen R. Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J Ethnopharmacol 1996; 52: 23-26. [DOI:10.1016/0378-8741(95)01330-X]

56. [25] Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 2001; 76: 45-48. [DOI:10.1016/S0378-8741(01)00216-1]

57. [26] Tamadonfard Z, Sepehrara L, Johari H. The effect of nigella sativa extract on learning and spatial memory of adult male rats. J Jahrom Univ Med Sci 2014; 12: 27-36. (Persian). [DOI:10.29252/jmj.12.1.27]

58. [27] Rahman M, Yang DK, Kim GB, Lee SJ, Kim SJ. Nigella sativa seed extract attenuates the fatigue induced by exhaustive swimming in rats. Biomed Rep 2017; 6: 468-474. [DOI:10.3892/br.2017.866] [PMID] [PMCID]

59. [28] Fathizadeh S, Amani R, Haghighizadeh MH, Hormozi R. Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: A case-control study. Int J Reprod Biomed (Yazd) 2016; 14: 699-704. (Persian). [DOI:10.29252/ijrm.14.11.699]

60. [29] Tofighiyan T, Kooshki A, Rakhshani MH. The effects of omega-3 fatty acids on premenstrual syndrome. Iran J Obstet Gynecol Infert 2013; 15: 23-28.

61. [30] Collins A, Cerin A, Coleman G, Landgren BM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993; 81: 93-98.

62. [31] Shah Hosseini Z, Danesh MM, Amin GH, SalehiSormaghi MH, Abedian K. Double blind study of anti-primary dysmenorrhea effects of Vitagnus. J Mazendaran Univ Med Sci 2005; 16: 15-21. (Persian).